HRA Pharma Breaks Into US Consumer Health Market With Mederma Acquisition
EllaOne and Compeed manufacturer HRA Pharma is set to establish a notable presence in the US consumer health market by acquiring the Mederma dermatology range from Germany's Merz.
You may also be interested in...
Exclusive: HBW Insight speaks to HRA Pharma CEO David Wright about the company's plans to become a top-10 global OTC player. Wright reveals that HRA is about to enter Latin America, beginning with Mexico and Brazil, and is currently looking at at least two significant acquisitions to ramp up its expansion plans in the coming months.
HRA Pharma brings Compeed to South Africa, moving the company one step closer to achieving its goal of becoming a top-10 global consumer healthcare player.
HRA is putting feet on the ground in China as it looks to establish itself in the world second-largest consumer health market.